112204 ⎘
Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
PCV2 ORF2 PROTEIN VARIANT AND VIRUS LIKE PARTICLES COMPOSED THEREOF
#2HEPATITIS E VIRUS-LIKE PARTICLES (VLPS) DERIVED FROM CONSENSUS SEQUENCES
#3Binding Domains Directed Against GPCR:G Protein Complexes and Uses Derived Thereof
#4PCV2 ORF2 protein variant and virus like particles composed thereof
#5BACULOVIRUS EXPRESSION VECTOR
#6Human monoclonal antibody human CD134 (OX40) and methods of making and using same
#7FURTHER IMPROVED AAV VECTORS PRODUCED IN INSECT CELLS
#8PCV2 ORF2 protein variant and virus like particles composed thereof
#9Binding domains directed against GPCR:G protein complexes and uses derived thereof
#10RECOMBINANT BACULOVIRUSES AND USES THEREOF
#11RABIES GLYCOPROTEIN VIRUS-LIKE PARTICLES (VLPS)
#12PCV2 ORF2 protein variant and virus like particles composed thereof
#13PCV2 ORF2 carrier platform
#14Human monoclonal antibody human CD134 (OX40) and methods of making and using same
#15Rabies glycoprotein virus-like particles (VLPS)
#16Further improved AAV vectors produced in insect cells
#17METHODS AND COMPOSITIONS FOR DISEASES ASSOCIATED WITH AMYLOIDOSIS
#18Compositions and methods related to viral vaccines
#19Methods and compositions for generating a mouse
#20Binding domains directed against GPCR:G protein complexes and uses derived thereof
#21Human monoclonal antibody human CD134 (OX40) and methods of making and using same
#22PCV2 ORF2 protein variant and virus like particles composed thereof
#23Methods of intracellular conversion of single-chain proteins into their di-chain form
#24Methods and compositions for generating a mouse
#25Recombinant fusion antigen gene, recombinant fusion antigen protein and subunit vaccine composition having the same against infection of porcine reproductive and respiratory syndrome virus
#26Universal influenza vaccine based on heterologous multiple M2E proteins
#27Isolated nucleic acid for the production of a vaccine against virus
#28Infectious bursal disease (IBDV) vaccine compositions
#29PCV2 ORF2 protein variant and virus like particles composed thereof
#30Vascular endothelial growth factor 2
#31Methods and compositions for generating a mouse
#32Vectors harboring toxic genes, methods and uses therefor
#33Binding domains directed against GPCR:G protein complexes and uses derived thereof
#34Compositions and methods for treating clostridium difficile-associated diseases
#35Polynucleotides and polypeptides involved in post-transcriptional gene silencing
#36Vaccine against multitypes of avian influenza viruses and uses thereof
#37Rabies glycoprotein virus-like particles (VLPS)
#38GPCR comprising an IC2 insertion
#39Human monoclonal antibody human CD134 (OX40) and methods of making and using same
#40Methods of intracellular conversion of single-chain proteins into their di-chain form
#41Methods for detecting an endotoxin using a horseshoe crab clotting enzyme
#42MAGE antigen binding proteins
#43Antagonist antibodies against EphB3
#44Compositions and Methods for Engineering Cells
#45Polynucleotides and polypeptides involved in post-transcriptional gene silencing
#46Methods of intracellular conversion of single-chain proteins into their di-chain form
#47AGENT THAT MODULATES PHYSIOLOGICAL CONDITION OF PESTS, INVOLVED IN INSECT PEPTIDYL-DIPEPTIDASE A ACTIVITY
#48ENHANCED MALARIA MSP-1 SUBUNIT VACCINE
#49GPCR comprising an IC2 insertion
#50VASCULAR ENDOTHELIAL GROWTH FACTOR 2
#51Cytokine zalpha11 ligand
#52ANTIBODIES SPECIFIC FOR DKK-1
#53Nanoparticle Based Immunological Stimulation
#54Novel tumor necrosis factor receptor homologs and nucleic acids encoding the same
#55Anti-IL-TIF antibodies and methods of use
#56MOLECULAR COMPLEXES WHICH MODIFY IMMUNE RESPONSES
#57IL-17 HOMOLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF
#58Recombinant merozoite surface proteins 4 and 5 and their use
#59Antibodies And Epitopes Specific To Misfolded Prion Protein
#60Norovirus capsid and rotavirus VP6 protein for use as combined vaccine
#61Methods and compositions for inhibiting the growth of hematopoietic malignant cells
#62Splice Switching Oligomers for TNF Superfamily Receptors and Their Use in Treatment of Disease
#63Production of Biologically Active Proteins
#64Process for Producing Recombinant Lyosomal Using Insect Larvae
#65Polynucleotides and polypeptides involved in post-transcriptional gene silencing
#66Polypeptides Homologous to VEGF and BMP1
#67Alzheimer's Disease Secretase, APP Substrates Therefor, and Uses Therefor
#68Compositions and Methods for Engineering Cells
#69MOLECULAR COMPLEXES WHICH MODIFY IMMUNE RESPONSES
#70Vascular endothelial growth factor 2
#71Human G-Protein Chemokine Receptor (CCR5) HDGNR10
#72Compositions and methods for detecting and modulating cell death by a translation regulated gene expression system
#73Polynucleotides and Polypeptides Encoding Receptors
#74Composition and methods for the diagnosis of immune related diseases involving the PRO52254 polypeptide
#75Human G-Protein Chemokine Receptor (CCR5) HDGNR10
#76POLYPEPTIDE AND DNA THEREOF USEFUL AS A NEOVASCULAR MARKER
#77Methods of treatment using antibodies to IL-17 homologous polypeptides
#78Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies
#79NUCLEIC ACIDS AND CORRESPONDING PROTEINS ENTITLED 58P1D12 USEFUL IN TREATMENT AND DETECTION OF CANCER
#80POLYPEPTIDES HOMOLOGOUS TO VEGF AND BMP1
#81Variants of humanized anti-carcinoma MAb CC49
#82Cytokine zalpha11 ligand antibodies
#83CYTOKINE ZALPHA11 LIGAND ANTIBODIES
#84RECOMBINANT PROTEIN CONTAINING A C-TERMINAL FRAGMENT OF PLASMODIUM MSP-1
#85Human G-Protein Chemokine Receptor (CCR5) HDGNR10
#86Antibodies to tumor associated proteins
#87Use of DR3 antibodies in the treatment of inflammatory disease
#88ANTIBODIES SPECIFICALLY REACTIVE WITH A TUMOR NECROSIS FACTOR RELATED LIGAND
#89Gene upregulated in cancers of the prostate
#90Purified polypeptide comprising or consisting of a C-terminus MSP1 antigen from carrying a Glycosyl-phosphatidyl-inositol group (GPI)
#91Cytokine zalpha11 ligand antibodies
#92Antibodies to tumor associated proteins
#93Human monoclonal antibody human CD134 (OX40) and methods of making and using same
#94Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies
#95BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells
#96HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR 2
#97Method for producing factor G derived from horseshoe crab
#98Methods and kits for diagnosis tumorgenicity
#99Antagonist antibodies against EPHB3
#100Recombinant merozoite surface proteins 4 and 5 and their use
#101Anti-IL-TIF antibodies and methods of making
#102DcR3 polypeptide, A TNFR homolog
#103Methods and compositions for inhibiting the growth of hematopoietic malignant cells
#104Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same
#105VASCULAR ENDOTHELIAL GROWTH FACTOR-2
#106Compositions and methods for WT1 specific immunotherapy
#107HUMAN VASCULAR IBP-LIKE GROWTH FACTOR
#108RECONSTITUTED HISTONE METHYLTRANSFERASE COMPLEX AND METHODS OF IDENTIFYI NG MODULATORS THEREOF
#109Methods to identify compounds useful for the treatment of proliferative and differentiative disorders
#110Insect cell line for production of recombinant glycoproteins with sulfated complex N-glycans
#111POLYPEPTIDES HOMOLOGOUS TO VEGF AND BMP1
#112Splice Switching Oligomers for TNF Superfamily Receptors and their Use in Treatment of Disease
#113Glial mitogenic factors, their preparation and use
#114Method of inhibiting human G-protein chemokine receptor (CCR5) HDGNR10
#115Recombinant expression of multiprotein complexes using polygenes
#116Anti-CD19 Antibody, Immunotoxin and Treatment Method
#117PRO1120 polypeptides
#118T24 antigen for immunodiagnosis of cysticercosis
#119PRO-CLOTTING ENZYME, AND METHOD FOR DETECTION OF ENDOTOXIN OR (1-3)-BETA-D-GLUCAN USING THE SAME
#120Polynucleotides and Polypeptides Encoding Receptors
#12188kDa tumorigenic growth factor and antagonists
#122METHODS AND COMPOSITIONS FOR DISEASES ASSOCIATED WITH AMYLOIDOSIS
#123NOVEL COMPOSITION AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES
#124Secreted and transmembrane polypeptides and nucleic acids encoding the same
#125Alzheimer's Disease Secretase, APP Substrates Thereof, and Uses Thereof
#126Methods and compositions for modulating and detecting wisp activity
#127SECRETED AND TRANSMEMBRANE POLYPEPTIDES AND NUCLEIC ACIDS ENCODING THE SAME
#128Anti-CD40 antibodies capable of blocking B-cell activation
#129Extracellular/Epidermal Growth Factor Like Protein
#130TRANSGENIC MICE EXPRESSING HYPERSENSITIVE NICOTINIC RECEPTORS
#131OBG3 globular head and uses thereof
#132Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies
#133COMPOSITIONS AND METHODS FOR REGULATING CELLULAR PROTECTION
#134Alzheimer's Disease Secretase, APP Substrates Therefor and Uses Therefor
#135Gene upregulated in cancers of the prostate
#136C-C chemokine receptor 3 proteins
#137Polynucleotides and polypeptides involved in post-transcriptional gene silencing
#138Vector expressing n-deacetylase/n-sulfotransferase 2
#139RECOMBINANT HUMAN ALPHA-FETOPROTEIN AS AN IMMUNOSUPPRESSIVE AGENT
#140Antibodies Against Human G-Protein Chemokine Receptor (CCR5) HDGNR10
#141Fibroblast Growth Factor-14
#142Vascular endothelial growth factor 2
#143Antibodies to IL-17 polypeptides and therapeutic uses thereof
#144POLYPEPTIDES HOMOLOGOUS TO VEGF AND BMP1
#145Method of delivery of nucleic acids to peripheral neurons
#146COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR
#147Antibodies to Chemokine Alpha-5
#148METH1 and METH2 Polynucleotides and Polypeptides
#149Autocrine growth factor receptor antibodies and methods
#150Novel tumor necrosis factor receptor homologs and nucleic acids encoding the same
#151POLYPEPTIDES HOMOLOGOUS TO VEGF AND BMP1
#152Secreted and transmembrane polypeptides and nucleic acids encoding the same
#153Recombinant merozoite surface proteins 4 and 5 and their use
#154Vascular endothelial growth factor 2
#155Cardiac myosin light chain kinase-specific antibodies and methods of detecting
#156Myeloid progenitor inhibitory factor-1 (MPIF-1) polypeptides
#157Polypeptide and DNA thereof useful as a neovascular marker
#158Genetic manipulation method
#159Human Nodal and Lefty Homologues
#160Reagent for measuring clotting time and method for stabilizing tissue factor
#161DIFFERENTIALLY EXPRESSED GENES INVOLVED IN ANGIOGENESIS, THE POLYPEPTIDES ENCODED THEREBY, AND METHODS OF USING THE SAME
#162Human G-Protein Chemokine Receptor (CCR5) HDGNR10
#163Polypeptide, novel DNA and novel antibody
#164Antibodies to human NK3-related prostate specific gene 1 proteins
#165Human Extracellular Matrix-1
#166Antibodies specific for Dkk-1
#167Non-Anaphylactogenic IgE Fusion Proteins
#168Anti-human VEGF receptor Flt-1 monoclonal antibody
#169ADIPOCYTE COMPLEMENT RELATED PROTEIN HOMOLOG ZACRP2
#17013-transmembrane protein expressed in prostate cancer
#171COMPOSITIONS AND METHODS FOR TREATMENT
#172Alzheimer's Disease Secretase, APP Substrates Therefor and Uses Therefor
#173DR3 antibodies
#174Antibodies to tumor associated proteins
#175DEVICES CONTAINING DNA ENCODING NEUROTROPHIC AGENTS AND RELATED COMPOSITIONS AND METHODS
#176Recombinant DNA molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections
#177Nucleic acids encoding monomers of a type II serine proteinase inhibitor
#178De novo DNA cytosine methyltransferase genes, polypeptides and uses thereof
#179POLYPEPTIDES HOMOLOGOUS TO VEGF AND BMP1
#180Method for making homozygous genetic modifications
#181Conditioned culture media
#182Antagonistic anti-CD40 antibodies
#183Polynucleotides and Polypeptides Encoding Receptors
#184Human Vascular IBP-Like Growth Factor
#185Variants of humanized anti-carcinoma MAb CC49
#186SECRETED AND TRANSMEMBRANE POLYPEPTIDES AND NUCLEIC ACIDS ENCODING THE SAME
#187Transformed cell harboring DNA or RNA encoding sugar chain synthesizing agent having β1,3-N-acetylglucosaminyltransferase activity
#188Antibodies against the PRO1754 polypeptides
#189Method for making genetic modifications
#190Human Neuropeptide Receptor
#191Galectin 11
#192Human tumor necrosis factor receptor TR9 antibody
#193Method for expressing a functional membrane-bound receptor protein using budded baculovirus
#194Fibroblast Growth Factor-13
#195T1 Receptor-Like Ligand II and Uses Thereof
#196Methods of treatment using antibodies to follistatin-3
#197Nucleic acids encoding OBG3 polypeptides
#198Antibodies against interleukin 17 receptor-like protein
#199Cell cycle progressional proteins
#200SECRETED AND TRANSMEMBRANE POLYPEPTIDES AND NUCLEIC ACIDS ENCODING THE SAME
#201Production of biologically active proteins
#202COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR
#203Novel Metalloproteinases
#204Antibodies to the PRO1561 polypeptide
#205USE OF IL-17 ANTIBODY FOR THE TREATMENT OF CARTILAGE DAMAGED BY OSTEOARTHRITIS
#206Compositions and methods for treating polycystic kidney disease gene
#207Interleukins-21 and 22
#208Antibodies to HTEEB42 protein
#209Proteins of natural origin and materials made therefrom
#210Mitogenic oxygenase regulators
#211Interleukins-21 and 22
#212Composition and method for modulating vasculogenesis for angiogenesis
#213IL-21 antagonists
#214Cytokine zalpha11 ligand fusion proteins
#215Interferon antagonists useful for the treatment of interferon related diseases
#216Monoclonal antibody specific for the extracellular domain of prostate specific membrane antigen
#217COMPOSITIONS COMPRISING ANTIBODIES TO HUMAN FGL2
#218CYTOKINE ZALPHA11 LIGAND
#219CYTOKINE ZALPHA11 LIGAND ANTIBODIES
#220CYTOKINE ZALPHA11 LIGAND ANTIBODIES
#221COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR
#222Cytokine zalpha11 ligand fusion proteins
#223Cytokine zalpha11 ligand fusion proteins
#224Method for expanding hematopoietic cells using cytokine zalpha11 ligand
#225Proteinase inhibitor, precursor thereof and genetic sequences encoding same
#226Cytokine zalpha11 ligand antibodies and methods of use
#227Nucleic acid and corresponding protein entitled 24P4C12 useful in treatment and detection of cancer
#228Methods of using cytokine zalpha11 ligand
#229CYTOKINE ZALPHA11 LIGAND FUSION PROTEINS
#230Method of treating allergy using antibody against human interleukin-5 receptor alpha chain
#231Cytokine zalpha11 ligand fusion proteins
#232Method of use of cytokine ZALPHA11 ligand
#233Dendritic Enriched Secreted Lymphocyte Activation Molecule
#234Nucleic acid encoding fused
#235CYTOKINE ZALPHA11 LIGAND ANTIBODIES
#236Recombinant protein containing a C-terminal fragment of Plasmodium MSP-1
#237Polypeptides homologous to VEGF and BMP1
#238Secreted and transmembrane polypeptides and nucleic acids encoding the same
#239Human Oncogene Induced Secreted Protein I
#240B Cell Activation and Polypeptides Having CD14 Activity
#241Cytokine zalpha11 ligand antibodies
#242HUMAN CCV POLYPEPTIDES
#243Transforming Growth Factor Alpha HI
#244Tumor necrosis factor related ligand
#245Human FGF-23 gene and gene expression products
#246Human voltage gated sodium channel β1A subunit and methods of use
#247T24 antigen for immunodiagnosis of cysticercosis
#248Antibodies to PRO1561 polypeptide
#249Extracellular matrix signalling molecules
#250Tumor necrosis factor related ligand
#251Method for producing factor G derived from horseshoe crab
#252Antibodies to myeloid progenitor inhibitory factor-1 (MPIF-1)
#253IL-I7 homologous polypeptides and therapeutic uses thereof
#254Antibodies to PRO1275 polypeptide
#255Human FGF-20 gene and gene expression products
#256Apoptosis inducing molecule I
#257Purified and isolated heparan sulfate 3--sulfotransferase isoform 5 nucleic acids and polypeptides and therapeutic and screening methods using same
#258Purified Stat proteins and methods of purifying thereof
#259Human serine protease and serpin polypeptides
#260Methods and compositions for modulating and detecting WISP activity
#261CD-44 like protein
#262Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same
#263Secreted and transmembrane polypeptides and nucleic acids encoding the same
#264Human G-protein chemokine receptor (CCR5) HDGNR10
#265RT-PCR-based cloning of human SMN, the SMA determining gene, and the construction of its expression plasmids
#266Method for generating an animal homozygous for a genetic modification
#267Secreted and transmembrane polypeptides and nucleic acids encoding the same
#268Secreted and transmembrane polypeptides and nucleic acids encoding the same
#269THE PRO4979 POLYPEPTIDE
#270De novo DNA cytosine methyltransferase genes, polypeptides and uses thereof
#271Methods for the identification of novel ligands for the g protein-coupled receptor (gpcr) 192
#272Antibodies to PRO 1120 polypeptide
#273Active modified hedgehog proteins
#274Secreted and transmembrane polypeptides and nucleic acids encoding the same
#275Methods and compositions for diseases associated with amyloidosis
#276Anti-Fc-gamma RIIB receptor antibody and uses therefor
#277Epidermal differentiation factor
#278Adipocyte complement related protein homolog zacrp7
#279Secreted and transmembrane polypeptides and nucleic acids encoding the same
#280Galectin 11
#281Anti-human VEGF receptor Flt-1 monoclonal antibody
#282Method of treating reproductive system cancer by administering follistatin-3
#283Identification of a novel bitter taste receptor T2R76 that specifically responds to brucine and prop bitter ligands
#284Recombinant protein containing a C-terminal fragment of MSP-1
#285Preparation of potent macrophage activating factors derived from cloned vitamin D binding protein and its domain and their therapeutic usage for cancer, HIV-infection and osteopetrosis
#286Expression receptors with 7 transmembrane domains in baculovirus-insect cell system
#287Antibodies to Chemokine Alpha-5
#288Peptides and methods for cell death regulation
#289Non-anaphylactogenic IgE fusion proteins
#290C-C chemokine receptor 3 proteins
#291RTD receptor
#292Genes for male accessory gland proteins in
#293Antibodies to human vascular endothelial growth factor 2 and methods of using the same
#294Methods of treatment with TR10 polypeptides
#295Method of treating atopic dermatitis using antibody against human interleukin-5 receptor alpha chain
#296CD40 splice variants, compositions for making and methods of using the same
#297Reconstituted histone methyltransferase complex and methods of identifying modulators thereof
#298DNA molecules encoding ligand-gated ion channels from
#299Vascular endothelial growth factor 2
#300Methods of treatment with TNFR5